Level 3: Breast and endocrine
Level 2: Tumour syndromes
Version 1.20
|
review
|
Not set
|
Sources
- Radboud University Medical Center, Nijmegen
Phenotypes
- Estrogen resistance, 615363
- {HDL response to hormone replacement, augmented}
- {Migraine, susceptibility to}, 157300
- {Atherosclerosis, susceptibility to}
- {Myocardial infarction, susceptibility to}, 608446
- {Breast cancer}, 114480 (1)
|
Level 3: Other hearing and ear disorders
Level 2: Hearing and ear disorders
Version 1.3
|
review
|
Not set
|
Sources
|
Level 3: Arteriopathies
Level 2: Cardiovascular disorders
Version 1.30
|
review
|
Not set
|
Sources
- Radboud University Medical Center, Nijmegen
Phenotypes
- Estrogen resistance, 615363
- {HDL response to hormone replacement, augmented}
- {Migraine, susceptibility to}, 157300
- {Atherosclerosis, susceptibility to}
- {Myocardial infarction, susceptibility to}, 608446
- {Breast cancer}, 114480 (1)
- {HDL response to hormone replacement, augmented}
- {Migraine, susceptibility to}, 157300
- {Atherosclerosis, susceptibility to}
- {Myocardial infarction, susceptibility to}, 608446
- {Breast cancer}, 114480 (1)
|
Level 3: Breast and endocrine
Level 2: Tumour syndromes
Version 4.3
Latest signed off version: v4.0
(22 Mar 2023)
|
review
|
Not set
|
Sources
- Radboud University Medical Center, Nijmegen
Phenotypes
- Estrogen resistance, 615363
- {HDL response to hormone replacement, augmented}
- {Migraine, susceptibility to}, 157300
- {Atherosclerosis, susceptibility to}
- {Myocardial infarction, susceptibility to}, 608446
- {Breast cancer}, 114480 (1)
|
Level 3: Skeletal dysplasias
Level 2: Skeletal disorders
Version 4.63
Latest signed off version: v4.0
(22 Mar 2023)
Component of the following Super Panels:
Paediatric disorders
|
review
|
Not set
|
Sources
|
Level 3: Skeletal dysplasias
Level 2: Skeletal disorders
Version 4.5
Latest signed off version: v4.0
(22 Mar 2023)
|
review
|
Not set
|
Sources
|